Accent Therapeutics
is a Massachusetts-based biopharmaceutical company that develops small-molecule precision therapies for the treatment of cancer... Read moreAccent Therapeutics
is a Massachusetts-based biopharmaceutical company that develops small-molecule precision therapies for the treatment of cancer... Read more
News
Apr 16, 2025
Clinical Trials Arena
Accent Therapeutics: Accent Therapeutics starts dosing in trial of KIF18A inhibitor for solid tumours
Mar 25, 2025
PR Newswire
Press Release: Accent Therapeutics : Accent Therapeutics to Present Data on Lead Programs ATX-559 and ATX-295 at the 2025 American Association for Cancer Research Annual Meeting
Dec 12, 2024
PR Newswire
Press Release: Accent Therapeutics : Accent Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of ATX-559 and Chief Scientific Officer Transition
Oct 25, 2024
Pharmabiz
Accent Therapeutics: US FDA clears Accent Therapeutics' IND application for ATX559, a firstinclass oral DHX9 inhibitor
Apr 09, 2024
PRWeb
Press Release: Accent Therapeutics : Accent Therapeutics Presents Data Supporting Two Lead Programs at AACR 2024 Annual Meeting
Mar 21, 2024
StreetInsider
Accent Therapeutics: Accent Therapeutics to Present Data Supporting DHX9 and KIF18A as Compelling Therapeutic Targets at American Association for Cancer Research (AACR) Annual Meeting 2024
Jan 23, 2024
BioPharma Dive
Accent Therapeutics: Pharmas back Accent's plan to make RNA-targeting cancer drugs
Jan 23, 2024
The Business Journals
Accent Therapeutics: Bristol Myers, J&J fund Lexington cancer biotech's move into the clinic
Jan 23, 2024
Endpoints News
Accent Therapeutics: Oncology biotech Accent raises $75M to enter the clinic
Sep 21, 2023
Citybizlist
Accent Therapeutics: Accent Therapeutics Expand Leadership Team
Accent Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10